vs
Side-by-side financial comparison of Sonoma Pharmaceuticals, Inc. (SNOA) and Valaris Ltd (VAL). Click either name above to swap in a different company.
Valaris Ltd is the larger business by last-quarter revenue ($5.2M vs $4.3M, roughly 1.2× Sonoma Pharmaceuticals, Inc.). Valaris Ltd runs the higher net margin — 13798.1% vs -18.8%, a 13816.9% gap on every dollar of revenue. On growth, Valaris Ltd posted the faster year-over-year revenue change (405.9% vs 22.0%). Sonoma Pharmaceuticals, Inc. produced more free cash flow last quarter ($-811.0K vs $-34.1M). Over the past eight quarters, Valaris Ltd's revenue compounded faster (29.5% CAGR vs 12.5%).
Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical firm focused on developing, manufacturing and selling dermatology and wound care products. It operates across North America, Europe and Asia, with offerings covering acne treatment, skin infection management, post-surgical wound recovery and chronic skin condition care for consumers and healthcare providers.
Valaris Limited is an offshore drilling contractor headquartered in Houston, Texas, and incorporated in Bermuda. It is the largest offshore drilling and well drilling company in the world. As of February 2025, it owned 52 rigs, including 36 offshore jackup rigs, 11 drillships, and 5 semi-submersible platform drilling rigs.
SNOA vs VAL — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.3M | $5.2M |
| Net Profit | $-819.0K | $717.5M |
| Gross Margin | 37.9% | -7850.0% |
| Operating Margin | -15.6% | — |
| Net Margin | -18.8% | 13798.1% |
| Revenue YoY | 22.0% | 405.9% |
| Net Profit YoY | 11.7% | 436.6% |
| EPS (diluted) | $-0.48 | $10.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.3M | $5.2M | ||
| Q3 25 | $5.6M | $5.6M | ||
| Q2 25 | $4.0M | $700.0K | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $3.6M | $-1.7M | ||
| Q3 24 | $3.6M | $3.9M | ||
| Q2 24 | $3.4M | $4.8M | ||
| Q1 24 | $3.4M | $2.6M |
| Q4 25 | $-819.0K | $717.5M | ||
| Q3 25 | $-534.0K | $188.1M | ||
| Q2 25 | $-1.2M | $115.1M | ||
| Q1 25 | $-776.0K | — | ||
| Q4 24 | $-928.0K | $133.7M | ||
| Q3 24 | $-610.0K | $64.6M | ||
| Q2 24 | $-1.1M | $149.6M | ||
| Q1 24 | $-1.1M | $25.5M |
| Q4 25 | 37.9% | -7850.0% | ||
| Q3 25 | 37.8% | -7142.9% | ||
| Q2 25 | 36.5% | -56428.6% | ||
| Q1 25 | 40.7% | — | ||
| Q4 24 | 35.6% | 24529.4% | ||
| Q3 24 | 38.0% | -11748.7% | ||
| Q2 24 | 38.5% | -9039.6% | ||
| Q1 24 | 31.7% | -17007.7% |
| Q4 25 | -15.6% | — | ||
| Q3 25 | -6.0% | — | ||
| Q2 25 | -27.3% | — | ||
| Q1 25 | -17.5% | — | ||
| Q4 24 | -28.9% | — | ||
| Q3 24 | -23.7% | — | ||
| Q2 24 | -34.6% | — | ||
| Q1 24 | -41.0% | — |
| Q4 25 | -18.8% | 13798.1% | ||
| Q3 25 | -9.5% | 3358.9% | ||
| Q2 25 | -30.9% | 16442.9% | ||
| Q1 25 | -20.7% | — | ||
| Q4 24 | -26.0% | -7864.7% | ||
| Q3 24 | -17.0% | 1656.4% | ||
| Q2 24 | -33.7% | 3116.7% | ||
| Q1 24 | -31.0% | 980.8% |
| Q4 25 | $-0.48 | $10.13 | ||
| Q3 25 | $-0.32 | $2.65 | ||
| Q2 25 | $-0.76 | $1.61 | ||
| Q1 25 | $-0.23 | — | ||
| Q4 24 | $-0.63 | $1.86 | ||
| Q3 24 | $-0.59 | $0.88 | ||
| Q2 24 | $-1.34 | $2.03 | ||
| Q1 24 | $-3.00 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6M | $599.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.4M | $3.2B |
| Total Assets | $13.6M | $5.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.6M | $599.4M | ||
| Q3 25 | $3.0M | $662.7M | ||
| Q2 25 | $3.6M | $503.4M | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $5.2M | $368.2M | ||
| Q3 24 | $4.1M | $379.3M | ||
| Q2 24 | $2.6M | $398.3M | ||
| Q1 24 | $3.1M | $494.1M |
| Q4 25 | $3.4M | $3.2B | ||
| Q3 25 | $3.8M | $2.4B | ||
| Q2 25 | $4.1M | $2.3B | ||
| Q1 25 | $4.4M | — | ||
| Q4 24 | $4.9M | $2.2B | ||
| Q3 24 | $5.4M | $2.1B | ||
| Q2 24 | $5.0M | $2.2B | ||
| Q1 24 | $6.1M | $2.0B |
| Q4 25 | $13.6M | $5.3B | ||
| Q3 25 | $13.9M | $4.6B | ||
| Q2 25 | $14.6M | $4.5B | ||
| Q1 25 | $13.7M | — | ||
| Q4 24 | $13.7M | $4.4B | ||
| Q3 24 | $13.7M | $4.3B | ||
| Q2 24 | $13.7M | $4.4B | ||
| Q1 24 | $14.7M | $4.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-764.0K | $72.2M |
| Free Cash FlowOCF − Capex | $-811.0K | $-34.1M |
| FCF MarginFCF / Revenue | -18.6% | -655.8% |
| Capex IntensityCapex / Revenue | 1.1% | 2044.2% |
| Cash ConversionOCF / Net Profit | — | 0.10× |
| TTM Free Cash FlowTrailing 4 quarters | $-3.7M | $159.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-764.0K | $72.2M | ||
| Q3 25 | $-635.0K | $198.1M | ||
| Q2 25 | $-2.0M | $120.0M | ||
| Q1 25 | $-95.0K | — | ||
| Q4 24 | $565.0K | $124.6M | ||
| Q3 24 | $354.0K | $193.0M | ||
| Q2 24 | $-912.0K | $11.5M | ||
| Q1 24 | $152.0K | $26.3M |
| Q4 25 | $-811.0K | $-34.1M | ||
| Q3 25 | $-645.0K | $128.3M | ||
| Q2 25 | $-2.1M | $52.8M | ||
| Q1 25 | $-142.0K | — | ||
| Q4 24 | $563.0K | $12.9M | ||
| Q3 24 | $328.0K | $111.1M | ||
| Q2 24 | $-917.0K | $-98.7M | ||
| Q1 24 | $134.0K | $-125.0M |
| Q4 25 | -18.6% | -655.8% | ||
| Q3 25 | -11.5% | 2291.1% | ||
| Q2 25 | -52.8% | 7542.9% | ||
| Q1 25 | -3.8% | — | ||
| Q4 24 | 15.8% | -758.8% | ||
| Q3 24 | 9.2% | 2848.7% | ||
| Q2 24 | -27.0% | -2056.3% | ||
| Q1 24 | 3.9% | -4807.7% |
| Q4 25 | 1.1% | 2044.2% | ||
| Q3 25 | 0.2% | 1246.4% | ||
| Q2 25 | 2.6% | 9600.0% | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.1% | -6570.6% | ||
| Q3 24 | 0.7% | 2100.0% | ||
| Q2 24 | 0.1% | 2295.8% | ||
| Q1 24 | 0.5% | 5819.2% |
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.93× | ||
| Q3 24 | — | 2.99× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SNOA
| Products | $3.9M | 89% |
| Other | $486.0K | 11% |
VAL
Segment breakdown not available.
